ncRNAs and polyphenols: new therapeutic strategies for hypertension

References

• Wulandari C. The effect of flavonoid consumption on blood pressure: a systematic review. Open Access Indonesian Journal of Medical Reviews. 2022;2(1):186–192.
   Google Scholar
• Derhaschnig U, Testori C, Riedmueller E, et al. Hypertensive emergencies are associated with elevated markers of inflammation, coagulation, platelet activation and fibrinolysis. J Hum Hypertens. 2013;27(6):368–373.
   PubMed Web of Science ®Google Scholar
• Lugo-Gavidia LM, Burger D, Matthews VB, et al. Role of microparticles in cardiovascular disease: implications for endothelial dysfunction, thrombosis, and inflammation. Hypertension. 2021;77(6):1825–1844.
   PubMed Web of Science ®Google Scholar
• Yamagata K. prevention of vascular endothelial dysfunction by polyphenols: role in cardiovascular disease prevention. In: Phytopharmaceuticals: potential therapeutic applications. Wiley Online Library; 2021. p. 223–246. doi:10.1002/9781119682059.ch11
   Google Scholar
• Tanghe A, Heyman E, Vanden Wyngaert K, et al. Evaluation of blood pressure lowering effects of cocoa flavanols in diabetes mellitus: a systematic review and meta-analysis. J Funct Foods. 2021;79:104399.
   Web of Science ®Google Scholar
• Hooper L, Kay C, Abdelhamid A, et al. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr. 2012;95(3):740–751.
   PubMed Web of Science ®Google Scholar
• Lapuente M, Estruch R, Shahbaz M, et al. Relation of fruits and vegetables with major cardiometabolic risk factors, markers of oxidation, and inflammation. Nutrients. 2019;11(10):2381.
   PubMed Web of Science ®Google Scholar
• Andriantsitohaina R, Auger C, Chataigneau T, et al. Molecular mechanisms of the cardiovascular protective effects of polyphenols. Br J Nutr. 2012;108(9):1532–1549.
   PubMed Web of Science ®Google Scholar
• Bátkai S, Thum T. MicroRNAs in hypertension: mechanisms and therapeutic targets. Curr Hypertens Rep. 2012;14(1):79–87.
   PubMed Web of Science ®Google Scholar
• Salabi F, Jafari H, Navidpour S, et al. Systematic and computational identification of androctonus crassicauda long non-coding RNAs. Sci Rep. 2021;11(1):1–14.
   PubMed Web of Science ®Google Scholar
• Majidinia M, Karimian A, Alemi F, et al. Targeting miRNAs by polyphenols: novel therapeutic strategy for aging. Biochem Pharmacol. 2020;173:113688.
   PubMed Web of Science ®Google Scholar
• Miranda A, Steluti J, Fisberg RM, et al. Dietary intake and food contributors of polyphenols in adults and elderly adults of Sao Paulo: a population-based study. Br J Nutr. 2016;115(6):1061–1070.
   PubMed Web of Science ®Google Scholar
• Singla RK, Dubey AK, Garg A, et al. Natural polyphenols: chemical classification, definition of classes, subcategories, and structures. J AOAC Int. 2019;102(5):1397–1400.
   PubMed Web of Science ®Google Scholar
• Bellavia D, Caradonna F, Dimarco E, et al. Non-flavonoid polyphenols in osteoporosis: preclinical evidence. Trends Endocrinol Metab. 2021;32(7):515–529.
   PubMed Web of Science ®Google Scholar
• Habauzit V, Morand C. Evidence for a protective effect of polyphenols-containing foods on cardiovascular health: an update for clinicians. Ther Adv Chronic Dis. 2012;3(2):87–106.
   PubMedGoogle Scholar
• Hügel HM, Jackson N, May B, et al. Polyphenol protection and treatment of hypertension. Phytomedicine. 2016;23(2):220–231.
   PubMed Web of Science ®Google Scholar
• Pehlivan FE. Diet-Epigenome interactions: epi-drugs modulating the epigenetic machinery during cancer prevention. In: Epigenetics to optogenetics-a new paradigm in the study of biology. IntechOpen; 2021. p. 18. doi:10.5772/intechopen.95374.
   Google Scholar
• Tsao R. Chemistry and biochemistry of dietary polyphenols. Nutrients. 2010;2(12):1231–1246.
   PubMed Web of Science ®Google Scholar
• Yi J, Li S, Wang C, et al. Potential applications of polyphenols on main ncRNAs regulations as novel therapeutic strategy for cancer. Biomed Pharmacother. 2019;113:108703.
   PubMed Web of Science ®Google Scholar
• Hemati N, Asis M, Moradi S, et al. Effects of genistein on blood pressure: a systematic review and meta-analysis. Food Res Int. 2020;128:108764.
   PubMed Web of Science ®Google Scholar
• Mohammadi M, Ramezani-Jolfaie N, Lorzadeh E, et al. Hesperidin, a major flavonoid in Orange juice, might not affect lipid profile and blood pressure: a systematic review and meta‐analysis of randomized controlled clinical trials. Phytother Res. 2019;33(3):534–545.
   PubMed Web of Science ®Google Scholar
• Liang Y, Wang J, Gao H, et al. Beneficial effects of grape seed proanthocyanidin extract on arterial remodeling in spontaneously hypertensive rats via protecting against oxidative stress. Mol Med Rep. 2016;14(4):3711–3718.
   PubMed Web of Science ®Google Scholar
• Garcia C, Blesso CN. Antioxidant properties of anthocyanins and their mechanism of action in atherosclerosis. Free Radic Biol Med. 2021;172:152–166.
   PubMed Web of Science ®Google Scholar
• Dos Baiao DS, da Silva DV, Paschoalin VM. Beetroot, a remarkable vegetable: its nitrate and phytochemical contents can be adjusted in novel formulations to benefit health and support cardiovascular disease therapies. Antioxidants. 2020;9(10):960.
   Web of Science ®Google Scholar
• Najjar RS, Feresin RG. Protective role of polyphenols in heart failure: molecular targets and cellular mechanisms underlying their therapeutic potential. Int J Mol Sci. 2021;22(4):1668.
   PubMed Web of Science ®Google Scholar
• Tangney CC, Rasmussen HE. Polyphenols, inflammation, and cardiovascular disease. Curr Atheroscler Rep. 2013;15(5):1–10.
   Web of Science ®Google Scholar
• Markovics A, Biró A, Kun-Nemes A, et al. Effect of anthocyanin-rich extract of sour cherry for hyperglycemia-induced inflammatory response and impaired endothelium-dependent vasodilation. Nutrients. 2020;12(11):3373.
   PubMed Web of Science ®Google Scholar
• Sha W, Liu M, Sun D, et al. Resveratrol ameliorated endothelial injury of thoracic aorta in diabetic mice and Gly‐LDL‐induced HUVECs through inhibiting TLR4/HIF‐1α. J Cell Mol Med. 2021;25(13):6258–6270.
   PubMed Web of Science ®Google Scholar
• Chen C-Y, Jin, X., Yi, L., et al. Inhibitory effect of delphinidin on monocyte–endothelial cell adhesion induced by oxidized low-density lipoprotein via ROS/p38MAPK/NF-κB pathway. Cell Biochem Biophys. 2011;61(2):337–348.
   PubMed Web of Science ®Google Scholar
• Poloni DM, Dangles O, Vinson JA. Binding of plant polyphenols to serum albumin and LDL: healthy implications for heart disease. J Agric Food Chem. 2019;67(33):9139–9147.
   PubMed Web of Science ®Google Scholar
• Tung W-C, Rizzo B, Dabbagh Y, et al. Polyphenols bind to low density lipoprotein at biologically relevant concentrations that are protective for heart disease. Arch Biochem Biophys. 2020;694:108589.
   PubMed Web of Science ®Google Scholar
• Monsalve B, Concha-meyer A, Palomo I, et al. Mechanisms of endothelial protection by natural bioactive compounds from fruit and vegetables. Anais da Academia Brasileira de Ciências. 2017;89(1 suppl):615–633.
   PubMed Web of Science ®Google Scholar
• Steven S, Frenis, K., Oelze, M., et al. Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease. Oxidative medicine and cellular longevity. 2019.
   Google Scholar
• Yamagata K. Polyphenols regulate endothelial functions and reduce the risk of cardiovascular disease. Curr Pharm Des. 2019;25(22):2443–2458.
   PubMed Web of Science ®Google Scholar
• Mozos I, Flangea C, Vlad DC, et al. Effects of anthocyanins on vascular health. Biomolecules. 2021;11(6):811.
   PubMed Web of Science ®Google Scholar
• Silva H, Lopes NMF. Cardiovascular effects of caffeic acid and its derivatives: a comprehensive review.Frontiers in physiology. 2020. p. 20.
   Google Scholar
• Tan CS, Loh YC, Tew WY, et al. Vasorelaxant effect of 3,5,4′-trihydroxy-trans-stilbene (resveratrol) and its underlying mechanism. Inflammopharmacology. 2020;28(4):869–875.
   PubMed Web of Science ®Google Scholar
• Mirhadi E, Roufogalis BD, Banach M, et al. Resveratrol: mechanistic and therapeutic perspectives in pulmonary arterial hypertension. Pharmacol Res. 2021;163:105287.
   PubMed Web of Science ®Google Scholar
• Fragopoulou E, Argyrou C, Detopoulou M, et al. The effect of moderate wine consumption on cytokine secretion by peripheral blood mononuclear cells: a randomized clinical study in coronary heart disease patients. Cytokine. 2021;146:155629.
   PubMed Web of Science ®Google Scholar
• Liu X, Martin DA, Valdez JC, et al. Aronia berry polyphenols have matrix-dependent effects on the gut microbiota. Food Chem. 2021;359:129831.
   PubMed Web of Science ®Google Scholar
• Bian Y, Liu P, Zhong J, et al. Quercetin attenuates adhesion molecule expression in intestinal microvascular endothelial cells by modulating multiple pathways. Dig Dis Sci. 2018;63(12):3297–3304.
   PubMed Web of Science ®Google Scholar
• Gomes AQ, Nolasco S, Soares H. Non-coding RNAs: multi-tasking molecules in the cell. Int J Mol Sci. 2013;14(8):16010–16039.
   PubMed Web of Science ®Google Scholar
• Fernandes JC, Acuña S, Aoki J, et al. Long non-coding RNAs in the regulation of gene expression: physiology and disease. Noncoding RNA. 2019;5(1):17.
   PubMed Web of Science ®Google Scholar
• Todd LA, Bui-Marinos MP, Katzenback BA. Post-transcriptional regulation of frog innate immunity: discovery of frog microRNAs associated with antiviral responses and ranavirus infection using a Xenopus laevis skin epithelial-like cell line. Facets. 2021;6(1):2058–2083.
   Google Scholar
• Bhaskaran M, Mohan M. MicroRNAs: history, biogenesis, and their evolving role in animal development and disease. Vet Pathol. 2014;51(4):759–774.
   PubMed Web of Science ®Google Scholar
• Eiring AM, Harb JG, Neviani P, et al. miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell. 2010;140(5):652–665.
   PubMed Web of Science ®Google Scholar
• Roberts TC. The microRNA biology of the mammalian nucleus. Mol Ther Nucleic Acids. 2014;3:e188.
   PubMedGoogle Scholar
• Mayr B, Niebauer J, Breitenbach-Koller H. Circulating miRNAs as predictors for morbidity and mortality in coronary artery disease. Mol Biol Rep. 2019;46(5):5661–5665.
   PubMed Web of Science ®Google Scholar
• Zhou S-S, Jin J-P, Wang J-Q, et al. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges. Acta Pharmacol Sin. 2018;39(7):1073–1084.
   PubMed Web of Science ®Google Scholar
• Shirazi-Tehrani E, Firouzabadi N, Tamaddon G, et al. Carvedilol alters circulating MiR-1 and MiR-214 in heart failure. Pharmgenomics Pers Med. 2020;13:375.
   PubMed Web of Science ®Google Scholar
• Kalayinia S, Arjmand F, Maleki M, et al. MicroRNAs: roles in cardiovascular development and disease. Cardiovasc Pathol. 2021;50:107296.
   PubMed Web of Science ®Google Scholar
• Lu P, Ding F, Xiang YK, et al. Noncoding RNAs in cardiac hypertrophy and heart failure. Cells. 2022;11(5):777.
   PubMed Web of Science ®Google Scholar
• Andersen GB, Knudsen A, Hager H, et al. mi RNA profiling identifies deregulated mi RNA s associated with osteosarcoma development and time to metastasis in two large cohorts. Mol Oncol. 2018;12(1):114–131.
   PubMed Web of Science ®Google Scholar
• Bavishi C, Bangalore S, Messerli FH. Outcomes of intensive blood pressure lowering in older hypertensive patients. J Am Coll Cardiol. 2017;69(5):486–493.
   PubMed Web of Science ®Google Scholar
• Wu G, Jose PA, Zeng C. Noncoding RNAs in the regulatory network of hypertension. Hypertension. 2018;72(5):1047–1059.
   PubMed Web of Science ®Google Scholar
• Bahramali E, Firouzabadi N, Rajabi M, et al. Association of renin–angiotensin–aldosterone system gene polymorphisms with left ventricular hypertrophy in patients with heart failure with preserved ejection fraction: a case–control study. Ann Clin Exp Hypertens. 2017;39(4):371–376.
   Google Scholar
• Firouzabadi N, Tajik N, Bahramali E, et al. Gender specificity of a genetic variant of angiotensin-converting enzyme and risk of coronary artery disease. Mol Biol Rep. 2013;40(8):4959–4965.
   PubMed Web of Science ®Google Scholar
• Bahramali E, Rajabi M, Jamshidi J, et al. Association of ACE gene D polymorphism with left ventricular hypertrophy in patients with diastolic heart failure: a case–control study. BMJ open. 2016;6(2):e010282.
   PubMed Web of Science ®Google Scholar
• Murakami K. Non-coding RNAs and hypertension–unveiling unexpected mechanisms of hypertension by the dark matter of the genome. Curr Hypertens Rev. 2015;11(2):80–90.
   PubMedGoogle Scholar
• Marques F, Booth S, Charchar F. The emerging role of non-coding RNA in essential hypertension and blood pressure regulation. J Hum Hypertens. 2015;29(8):459–467.
   PubMed Web of Science ®Google Scholar
• Patel RS, Masi S, Taddei S. Understanding the role of genetics in hypertension. Eur Heart J. 2017;38(29):2309–2312.
   PubMed Web of Science ®Google Scholar
• Liyanage KIP, Ganegoda GU. Therapeutic Approaches and Role of ncRNAs in Cardiovascular Disorders and Insulin Resistance. BioMed Research International. 2017. p. 10.
   Google Scholar
• Jusic A, Devaux Y, Action E-C-C. Noncoding RNAs in hypertension. Hypertension. 2019;74(3):477–492.
   PubMed Web of Science ®Google Scholar
• Sequeira-Lopez MLS, Weatherford ET, Borges GR, et al. The microRNA-processing enzyme dicer maintains juxtaglomerular cells. J Am Soc Nephrol. 2010;21(3):460–467.
   PubMed Web of Science ®Google Scholar
• Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 2010;79:351–379.
   PubMed Web of Science ®Google Scholar
• Ketting RF, Cochella L. Concepts and functions of small RNA pathways in C. elegans. Current topics in developmental biology. 2021. doi:10.1016/bs.ctdb.2020.08.002.
   Google Scholar
• Badawy HK, Abo-Elmatty DM, Mesbah NM. Differential expression of microRNA let-7e and 296-5p in plasma of Egyptian patients with essential hypertension. Heliyon. 2018;4(11):e00969.
   PubMed Web of Science ®Google Scholar
• Li S, Zhu J, Zhang W, et al. Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation. 2011;124(2):175–184.
   PubMed Web of Science ®Google Scholar
• Wei L-H, Huang X-R, Zhang Y, et al. Smad7 inhibits angiotensin II-induced hypertensive cardiac remodelling. Cardiovasc Res. 2013;99(4):665–673.
   PubMed Web of Science ®Google Scholar
• Nemecz M, Alexandru N, Tanko G, et al. Role of microRNA in endothelial dysfunction and hypertension. Curr Hypertens Rep. 2016;18(12):87.
   PubMed Web of Science ®Google Scholar
• Zhuo Y, Zeng Q, Zhang P, et al. Functional polymorphism of lncRNA MALAT1 contributes to pulmonary arterial hypertension susceptibility in Chinese people. Clin Chem Lab Med. 2017;55(1):38–46.
   PubMed Web of Science ®Google Scholar
• Shi L, Tian C, Sun L, et al. The lncRNA TUG1/miR-145-5p/FGF10 regulates proliferation and migration in VSMCs of hypertension. Biochem Biophys Res Commun. 2018;501(3):688–695.
   PubMed Web of Science ®Google Scholar
• Jin Q, Zhao, Z., Zhao, Q., et al. Long noncoding RNAs: emerging roles in pulmonary hypertension. In: Heart failure reviews. 2019. p. 795–815.
   Google Scholar
• Sekar D, Nallaswamy D, Lakshmanan G. Decoding the functional role of long noncoding RNAs (lncRNAs) in hypertension progression. In: Hypertension research. 2020. p. 724–725.
   Google Scholar
• Jiang X, Ning Q. Long noncoding RNAs as novel players in the pathogenesis of hypertension In: Hypertension Research. SpringerNature; 2020. p. 597–608.
   Google Scholar
• Wu Y-X, Zhang S-H, Cui J, et al. Long noncoding RNA XR007793 regulates proliferation and migration of vascular smooth muscle cell via suppressing miR-23b. Med Sci Monit. 2018;24:5895.
   PubMed Web of Science ®Google Scholar
• Jin L, Lin, X., Yang, L., et al. AK098656, a novel vascular smooth muscle cell–dominant long noncoding RNA, promotes hypertension. Hypertension. 2018;71(2):262–272.
   PubMed Web of Science ®Google Scholar
• Hou J, Wang L, Wu Q, et al. Long noncoding RNA H19 upregulates vascular endothelial growth factor A to enhance mesenchymal stem cells survival and angiogenic capacity by inhibiting miR-199a-5p. Stem Cell Res Ther. 2018;9(1):1–12.
   PubMedGoogle Scholar
• Wang Y-N-Z, Shan K, Yao M-D, et al. Long noncoding RNA-GAS5: a novel regulator of hypertension-induced vascular remodeling. Hypertension. 2016;68(3):736–748.
   PubMed Web of Science ®Google Scholar
• Rudra A, Arvind I, Mehra R. Polyphenols: types, sources and therapeutic applications. Int J Home Sci. 2021;7(3):69–75
   Google Scholar
• Song F-L, Gan R-Y, Zhang Y, et al. Total phenolic contents and antioxidant capacities of selected Chinese medicinal plants. Int J Mol Sci. 2010;11(6):2362–2372.
   PubMed Web of Science ®Google Scholar
• Ra J-E, Woo S-Y, Jin H, et al. Evaluation of antihypertensive polyphenols of barley (Hordeum vulgare L.) seedlings via their effects on angiotensin-converting enzyme (ACE) inhibition. Appl Biol Chem. 2020;63(1):1–9.
   Web of Science ®Google Scholar
• Chen Y-P, Sivalingam K, Shibu MA, et al. Protective effect of Fisetin against angiotensin II-induced apoptosis by activation of IGF-IR-PI3K-Akt signaling in H9c2 cells and spontaneous hypertension rats. Phytomedicine. 2019;57:1–8.
   PubMed Web of Science ®Google Scholar
• Polyphenols: mechanisms of Action in Human Health and Disease
   Google Scholar
• Boo YC. Can plant phenolic compounds protect the skin from airborne particulate matter? Antioxidants. 2019;8(9):379.
   Web of Science ®Google Scholar
• Gerhauser C. Epigenetics, Plant (Poly) phenolics, and Cancer Prevention. In: Recent advances in polyphenol research first 4. John Wiley & Sons; 2014. p. 143–207.
   Google Scholar
• Milenkovic D, Jude B, Morand C. miRNA as molecular target of polyphenols underlying their biological effects. Free Radic Biol Med. 2013;64:40–51.
   PubMed Web of Science ®Google Scholar
• Milenkovic D, Deval C, Gouranton E, et al. Modulation of miRNA expression by dietary polyphenols in apoE deficient mice: a new mechanism of the action of polyphenols. PloS one. 2012;7(1):e29837.
   PubMed Web of Science ®Google Scholar
• Han X, Wang C, Li Y, et al. miR-29b in regulating blood pressure and cardiac function in the rat model of hypertension. Exp Ther Med. 2019;17(5):3361–3366.
   PubMed Web of Science ®Google Scholar
• Tsai M-J, Chang W-A, Liao S-H, et al. The effects of Epigallocatechin Gallate (EGCG) on pulmonary fibroblasts of Idiopathic Pulmonary Fibrosis (IPF)—A next-generation sequencing and bioinformatic approach. Int J Mol Sci. 2019;20(8):1958.
   PubMed Web of Science ®Google Scholar
• Ren D, Li F, Gao A, et al. Hypoxia-induced apoptosis of cardiomyocytes is restricted by ginkgolide B-downregulated microRNA-29. Cell Cycle. 2020;19(10):1067–1076.
   PubMed Web of Science ®Google Scholar
• Tomé-Carneiro J, Larrosa M, Yáñez-Gascón MJ, et al. One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease. Pharmacol Res. 2013;72:69–82.
   PubMed Web of Science ®Google Scholar
• Ramanujam D, Schön AP, Beck C, et al. MicroRNA-21–dependent macrophage-to-fibroblast signaling determines the cardiac response to pressure overload. Circulation. 2021;143(15):1513–1525.
   PubMed Web of Science ®Google Scholar
• Abd-Aziz N, Kamaruzman NI, Poh CL. Development of MicroRNAs as potential therapeutics against cancer. J Oncol. 2020;2020.
   PubMed Web of Science ®Google Scholar
• Liu Y-Y, Zhang WY, Wang CG, et al. Resveratrol prevented experimental pulmonary vascular remodeling via miR-638 regulating NR4A3/cyclin D1 pathway. Microvasc Res. 2020;130 103988.
   PubMed Web of Science ®Google Scholar
• Qian B-J, Tian -C-C, Ling X-H, et al. miRNA-150-5p associate with antihypertensive effect of epigallocatechin-3-gallate revealed by aorta miRNome analysis of spontaneously hypertensive rat. Life Sci. 2018;203:193–202.
   PubMed Web of Science ®Google Scholar
• Rajabi S, Najafipour H, Jafarinejad Farsangi S, et al. Perillyle alcohol and Quercetin ameliorate monocrotaline-induced pulmonary artery hypertension in rats through PARP1-mediated miR-204 down-regulation and its downstream pathway. BMC Complementary Medicine and Therapies. 2020;20(1):1–12.
   PubMedGoogle Scholar
• Kawai Y, Nishikawa T, Shiba Y, et al. Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries implication in the anti-atherosclerotic mechanism of dietary flavonoids. J Biol Chem. 2008;283(14):9424–9434.
   PubMed Web of Science ®Google Scholar
• Solich J, Kuśmider M, Faron-Górecka A, et al. Serum level of miR-1 and miR-155 as potential biomarkers of stress-resilience of NET-KO and SWR/J mice. Cells. 2020;9(4):917.
   PubMed Web of Science ®Google Scholar
• Bladé C, Baselga-Escudero L, Salvadó MJ, et al. mi RNA s, polyphenols, and chronic disease. Mol Nutr Food Res. 2013;57(1):58–70.
   PubMed Web of Science ®Google Scholar
• Boesch-Saadatmandi C, Loboda A, Wagner AE, et al. Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155. J Nutr Biochem. 2011;22(3):293–299.
   PubMed Web of Science ®Google Scholar
• Pinkney HR, Wright BM, Diermeier SD. The lncRNA toolkit: databases and in silico tools for lncRNA analysis. Noncoding RNA. 2020;6(4):49.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yang X, Lin Y, et al. Anti-hypertensive effect of Lycium barbarum L. with down-regulated expression of renal endothelial lncRNA sONE in a rat model of salt-sensitive hypertension. Int J Clin Exp Pathol. 2015;8(6):6981.
   PubMed Web of Science ®Google Scholar
• Zhu A, Chu L, Ma Q, et al. Long non-coding RNA H19 down-regulates miR-181a to facilitate endothelial angiogenic function. Artif Cells Nanomed Biotechnol. 2019;47(1):2698–2705.
   PubMed Web of Science ®Google Scholar
• Lin K-H, Shibu MA, Peramaiyan R, et al. Bioactive flavone fisetin attenuates hypertension associated cardiac hypertrophy in H9c2 cells and in spontaneously hypertension rats. J Funct Foods. 2019;52:212–218.
   Web of Science ®Google Scholar
• Pons Z, Margalef M, Bravo FI, et al. Grape seed flavanols decrease blood pressure via Sirt-1 and confer a vasoprotective pattern in rats. J Funct Foods. 2016;24:164–172.
   Web of Science ®Google Scholar
• Liu K, YING Z, QI X, et al. MicroRNA-1 regulates the proliferation of vascular smooth muscle cells by targeting insulin-like growth factor 1. Int J Mol Med. 2015;36(3):817–824.
   PubMed Web of Science ®Google Scholar
• Zhang W-F, Zhu, T. T., Xiong, Y. W., et al. Negative feedback regulation between microRNA let-7g and LOX-1 mediated hypoxia-induced PASMCs proliferation. Biochem Biophys Res Commun. 2017;488(4):655–663.
   PubMed Web of Science ®Google Scholar
• Zhang B, Yao, Y., Sun, Q. F., et al. Circulating mircoRNA-21 as a predictor for vascular restenosis after interventional therapy in patients with lower extremity arterial occlusive disease. Biosci Rep. 2017;37 (2):1–10.
   Google Scholar
• Carr G, Barrese V, Stott JB, et al. MicroRNA-153 targeting of KCNQ4 contributes to vascular dysfunction in hypertension. Cardiovasc Res. 2016;112(2):581–589.
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu G, Zhang H, et al. MiRNA-199a-5p influences pulmonary artery hypertension via downregulating Smad3. Biochem Biophys Res Commun. 2016;473(4):859–866.
   PubMed Web of Science ®Google Scholar
• Yang F, Li H, Du Y, et al. Downregulation of microRNA‑34b is responsible for the elevation of blood pressure in spontaneously hypertensive rats. Mol Med Rep. 2017;15(3):1031–1036.
   PubMed Web of Science ®Google Scholar
• Huber LC, Ulrich, S., Leuenberger, C., et al. Featured article: microRNA-125a in pulmonary hypertension: regulator of a proliferative phenotype of endothelial cells. Exp Biol Med. 2015;240(12):1580–1589.
   Web of Science ®Google Scholar
• Kang B-Y, Park KK, Kleinhenz JM, et al. Peroxisome proliferator–activated receptor γ and microRNA 98 in hypoxia-induced endothelin-1 signaling. Am J Respir Cell Mol Biol. 2016;54(1):136–146.
   PubMed Web of Science ®Google Scholar
• Jin Y, Pang T, Nelin LD, et al. MKP‐1 is a target of miR‐210 and mediate the negative regulation of miR‐210 inhibitor on hypoxic hPASMC proliferation. Cell Biol Int. 2015;39(1):113–120.
   PubMed Web of Science ®Google Scholar
• Xing Y, Zheng X, Li G, et al. MicroRNA-30c contributes to the development of hypoxia pulmonary hypertension by inhibiting platelet-derived growth factor receptor β expression. Int J Biochem Cell Biol. 2015;64:155–166.
   PubMed Web of Science ®Google Scholar
• Gopalakrishnan K, Kumarasamy S, Mell B, et al. Genome-wide identification of long noncoding RNAs in rat models of cardiovascular and renal disease. Hypertension. 2015;65(1):200–210.
   PubMed Web of Science ®Google Scholar
• Michalik KM, You, X., Manavski, Y., et al. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res. 2014;114(9):1389–1397.
   PubMed Web of Science ®Google Scholar
• Bayoglu B, Yuksel H, Cakmak HA, et al. Polymorphisms in the long non-coding RNA CDKN2B-AS1 may contribute to higher systolic blood pressure levels in hypertensive patients. Clin Biochem. 2016;49(10–11):821–827.
   PubMed Web of Science ®Google Scholar
• Su H, Xu X, Yan C, et al. LncRNA H19 promotes the proliferation of pulmonary artery smooth muscle cells through AT 1 R via sponging let-7b in monocrotaline-induced pulmonary arterial hypertension. Respir Res. 2018;19(1):254.
   PubMed Web of Science ®Google Scholar